Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ARCT

Arcturus Therapeutics Holdings Inc

Dec 26 • 04:00PM ET

16.93

Dollar change +0.40
Percentage change 2.42	%

Healthcare • Biotechnology • USA • NASD

Peers: MRNA BNTX PFE NVAX DVAX INO VXRT ALT ADMA ADAP

| Held by: ARKG VTI XBI IWM VXF IWO IBB SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.21	Insider Own	9.25%	Shs Outstand	27.08M	Perf Week	14.24%
Market Cap	458.58M	Forward P/E	-	EPS next Y	-1.98	Insider Trans	-0.48%	Shs Float	24.58M	Perf Month	-3.70%
Income	-59.51M	PEG	-	EPS next Q	-0.56	Inst Own	88.46%	Short Float	18.07%	Perf Quarter	-22.23%
Sales	145.60M	P/S	3.15	EPS this Y	-144.71%	Inst Trans	-3.56%	Short Ratio	11.24	Perf Half Y	-30.76%
Book/sh	9.67	P/B	1.75	EPS next Y	18.91%	ROA	-14.37%	Short Interest	4.44M	Perf Year	-48.38%
Cash/sh	10.79	P/C	1.57	EPS next 5Y	-	ROE	-21.96%	52W Range	14.30 - 45.00	Perf YTD	-46.31%
Dividend Est.	-	P/FCF	-	EPS past 5Y	12.40%	ROI	-20.67%	52W High	-62.38%	Beta	2.63
Dividend TTM	-	Quick Ratio	4.76	Sales past 5Y	310.16%	Gross Margin	97.58%	52W Low	18.39%	ATR (14)	1.29
Dividend Ex-Date	-	Current Ratio	4.76	EPS Y/Y TTM	-159.03%	Oper. Margin	-20.91%	RSI (14)	48.33	Volatility	8.30% 7.27%
Employees	180	Debt/Eq	0.11	Sales Y/Y TTM	-50.30%	Profit Margin	-40.87%	Recom	1.00	Target Price	79.47
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	58.21%	Payout	-	Rel Volume	0.55	Prev Close	16.53
Sales Surprise	13.89%	EPS Surprise	78.62%	Sales Q/Q	-10.52%	Earnings	Nov 07 AMC	Avg Volume	395.05K	Price	16.93
SMA20	-1.44%	SMA50	-6.22%	SMA200	-30.11%	Trades		Volume	217,369	Change	2.42%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-12-24	Initiated	Leerink Partners	Outperform	$70
Dec-13-23	Initiated	Canaccord Genuity	Buy	$90
Jul-24-23	Initiated	William Blair	Outperform	$71
May-11-23	Upgrade	H.C. Wainwright	Neutral → Buy	$19 → $51
Nov-14-22	Resumed	Wells Fargo	Overweight	$35
Nov-10-22	Downgrade	Robert W. Baird	Neutral → Underperform	$18
Nov-03-22	Upgrade	Citigroup	Neutral → Buy	$22 → $35
Nov-02-22	Upgrade	Barclays	Underweight → Equal Weight	$16 → $25
Aug-10-22	Downgrade	Raymond James	Mkt Perform → Underperform
Jul-19-22	Resumed	Cantor Fitzgerald	Overweight	$86 → $39
May-11-22	Upgrade	Robert W. Baird	Underperform → Neutral	$21 → $18
Apr-21-22	Downgrade	Citigroup	Buy → Neutral	$86 → $29
Jan-31-22	Upgrade	Raymond James	Underperform → Mkt Perform
Aug-12-21	Downgrade	Raymond James	Mkt Perform → Underperform
Aug-11-21	Downgrade	Goldman	Neutral → Sell	$29
Aug-10-21	Downgrade	Robert W. Baird	Neutral → Underperform	$31
Jul-02-21	Initiated	Cantor Fitzgerald	Overweight	$71
Jun-25-21	Resumed	Goldman	Neutral	$29
Jun-21-21	Downgrade	Barclays	Equal Weight → Underweight	$33 → $25
Jun-04-21	Resumed	Robert W. Baird	Neutral	$31

Show Previous Ratings

Dec-16-24 04:01PM	Arcturus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) -5.64%
Dec-11-24 11:55AM	Why Arcturus Therapeutics (ARCT) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey)
Nov-26-24 04:01PM	Arcturus Therapeutics to Attend Upcoming Investor Conferences (Business Wire)
Nov-18-24 08:00PM	Arcturus Therapeutics to Present at Jefferies London Healthcare Conference (Business Wire) +11.00%
Nov-14-24 01:00AM	Meiji Seika Pharma Announces Investment in ARCALIS, Inc. (Business Wire)
04:01PM	Loading…
Nov-11-24 04:01PM	Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial (Business Wire)
Nov-08-24 12:15PM	Q3 2024 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
02:29AM	Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ... (GuruFocus.com)
Nov-07-24 05:55PM	Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:48PM	Arcturus Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress (Business Wire)
Nov-06-24 07:35AM	Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-31-24 04:01PM	Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024 (Business Wire)
Oct-30-24 12:00PM	Arcturus Therapeutics (ARCT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Oct-23-24 04:00AM	A slow start for self-amplifying mRNA vaccines (Pharmaceutical Technology)
11:12AM	Loading…
Sep-30-24 11:12AM	Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses (Benzinga) +5.36%
08:00AM	Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination (PR Newswire)
Sep-13-24 08:15AM	Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma (PR Newswire)
Sep-08-24 04:51PM	Arcturus Therapeutics Holdings Inc. (ARCT): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
Sep-03-24 08:30AM	Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis (Business Wire) -8.10%
Sep-02-24 09:55AM	Does Arcturus Therapeutics (ARCT) Have the Potential to Rally 216.35% as Wall Street Analysts Expect? (Zacks)
Aug-27-24 05:00PM	Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences (Business Wire)
Aug-23-24 12:00PM	What Makes Arcturus Therapeutics (ARCT) a New Strong Buy Stock (Zacks)
Aug-05-24 08:59PM	ARCT Stock Earnings: Arcturus Therapeutics Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:10PM	Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Arcturus Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Second Quarter 2024 Financial Update and Pipeline Progress (Business Wire)
Aug-01-24 04:01PM	Arcturus Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference (Business Wire) -8.01%
Jul-18-24 07:30PM	Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 5, 2024 (Business Wire)
04:01PM	Loading…
Jul-01-24 04:01PM	Arcturus Therapeutics Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) Programs (Business Wire) -9.21%
Jun-20-24 08:00AM	Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors (Business Wire)
Jun-15-24 02:49AM	Insider Sale: CFO Andy Sassine Sells 50,000 Shares of Arcturus Therapeutics Holdings Inc (ARCT) (GuruFocus.com)
Jun-07-24 10:30AM	Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference (Business Wire) -25.31%
Jun-04-24 07:00PM	Insider Sale: Chief Scientific Officer & COO Pad Chivukula Sells 26,000 Shares of Arcturus ... (GuruFocus.com) +7.17%
May-28-24 06:30AM	Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program (Business Wire) +26.31%
May-22-24 07:00AM	Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines (GlobeNewswire) +8.48%
May-20-24 08:30AM	Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine (PR Newswire)
May-15-24 04:01PM	Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences (Business Wire) +5.12%
May-09-24 11:13AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:48AM	Arcturus Therapeutics Holdings Inc (ARCT) (Q1 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
May-08-24 09:58PM	ARCT Stock Earnings: Arcturus Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:43PM	Arcturus Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress (Business Wire)
May-01-24 10:01AM	Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for (Zacks) +9.15%
Apr-25-24 04:01PM	Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024 (Business Wire)
Mar-28-24 01:34AM	Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares (GuruFocus.com)
Mar-22-24 01:26AM	Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ... (GuruFocus.com)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 12:10PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:54AM	Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-24 10:42PM	Arcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developments (GuruFocus.com)
05:10PM	Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:21PM	Arcturus Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress (Business Wire)
Mar-04-24 01:23PM	Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why (Zacks) -5.24%
Feb-26-24 03:20PM	7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff (InvestorPlace) +9.41%
09:00AM	Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference (Business Wire)
Feb-22-24 08:30AM	Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis (Business Wire) +6.12%
Feb-21-24 01:04PM	Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024 (InvestorPlace)
Feb-20-24 04:39PM	3 Tech Stocks That Could Be Multibaggers in the Making: February Edition (InvestorPlace)
09:00AM	Arcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024 (Business Wire)
Feb-05-24 08:30AM	New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster (PR Newswire)
Jan-23-24 04:16AM	18 High Growth Low PE Stocks (Insider Monkey)
Jan-05-24 01:17PM	PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics to Evaluate Transdermal mRNA delivery systems (PR Newswire)
Dec-21-23 08:00AM	CSL and Arcturus Therapeutics ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster (Business Wire)
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Dec-13-23 10:39PM	3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024 (InvestorPlace) +11.18% +8.05%
Dec-08-23 10:13AM	12 Best Healthcare Stocks For the Long-Term (Insider Monkey)
Dec-04-23 08:30AM	Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-28-23 08:05AM	Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults (PR Newswire)
07:56AM	Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up (Zacks)
Nov-27-23 08:30AM	Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis (Business Wire) +7.90%
Nov-15-23 01:26PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2023 Earnings Call Transcript (Insider Monkey) +16.08%
11:30AM	Q3 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-14-23 05:19PM	Arcturus Therapeutics Holdings Inc (ARCT) Reports Significant Revenue Growth in Q3 2023 (GuruFocus.com) +9.54%
04:13PM	Arcturus Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
10:56AM	The 3 Most Undervalued Biotech Stocks to Buy: November 2023 (InvestorPlace)
Oct-25-23 04:01PM	Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 14, 2023 (Business Wire)
Oct-23-23 04:01PM	Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences (Business Wire)
Oct-04-23 11:01PM	Insider Sell: Pad Chivukula Sells 5,000 Shares of Arcturus Therapeutics Holdings Inc (GuruFocus.com)
08:30AM	Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Additional Financial Grants from Japanese Government (Business Wire)
Sep-26-23 08:30AM	Arcturus Therapeutics and Cystic Fibrosis Foundation Extend Agreement to Advance ARCT-032, an Investigational Messenger RNA (mRNA) Therapeutic to Treat Cystic Fibrosis (Business Wire)
Sep-19-23 08:30AM	Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants (Business Wire)
Sep-05-23 08:30AM	Arcturus Therapeutics and CSL Announce European Medicines Agency Validates Marketing Authorization Application for ARCT-154 Vaccine to Prevent COVID-19 (Business Wire)
Aug-17-23 08:30AM	Arcturus Therapeutics to Attend Upcoming Investor Conferences (Business Wire)
Aug-14-23 09:00AM	Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government (Business Wire) +6.37%
Aug-10-23 07:15AM	New Strong Sell Stocks for August 10th (Zacks)
Aug-08-23 02:39PM	Why Shares of Arcturus Therapeutics Dropped on Tuesday (Motley Fool) -19.22%
01:09PM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2023 Earnings Call Transcript (Insider Monkey)
08:43AM	Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
07:39AM	Q2 2023 Arcturus Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 07:50PM	Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:43PM	Arcturus Therapeutics: Q2 Earnings Snapshot (AP Finance)
04:01PM	Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress (Business Wire)
Aug-04-23 09:21AM	4 Biotech Stocks Set to Outpace Q2 Earnings Estimates (Zacks)
Jul-28-23 05:14PM	3 Biotech Stocks to Buy Before the Breakout (InvestorPlace)
Jul-24-23 04:01PM	Arcturus Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 7, 2023 (Business Wire) +5.38%
Jul-18-23 06:22AM	3 Biotech Stocks for Getting Rich in 2023 (InvestorPlace)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chivukula Pad	Chief Scientific Officer & COO	Oct 15 '24	Sale	20.76	12,000	249,121	435,334	Oct 16 09:05 PM
Chivukula Pad	Officer	Oct 15 '24	Proposed Sale	20.76	12,000	249,121		Oct 15 04:29 PM
Marantz Jing L.	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:01 PM
HOLMES EDWARD W	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:01 PM
Markels John	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:00 PM
Marquet Magda	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	3,131	Jun 18 09:00 PM
BARLOW JAMES F	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	13,131	Jun 18 09:00 PM
FARRELL PETER C	Director	Jun 14 '24	Option Exercise	0.00	3,131	0	55,741	Jun 18 09:00 PM
SASSINE ANDY	Chief Financial Officer	Jun 12 '24	Sale	32.03	50,000	1,601,500	220,526	Jun 14 04:06 PM
Chivukula Pad	Chief Scientific Officer & COO	Jun 05 '24	Sale	45.00	114	5,130	447,334	Jun 07 05:01 PM
Chivukula Pad	Chief Scientific Officer & COO	Jun 03 '24	Sale	40.01	26,000	1,040,234	447,448	Jun 04 04:05 PM
Chivukula Pad	Chief Scientific Officer & COO	Mar 25 '24	Sale	35.02	17,435	610,574	473,448	Mar 27 04:15 PM
Chivukula Pad	Chief Scientific Officer & COO	Mar 19 '24	Sale	35.01	8,565	299,839	490,883	Mar 21 05:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ARCT

Arcturus Therapeutics Holdings Inc

Upgrade your FINVIZ experience